This inventor holds 21 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Cocrystals. Top assignees: Intercept Pharmaceuticals, Inc., Radius Pharmaceuticals, Inc., Manoira Corporation. Active years: 2009-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 62 
6 out of 19 
3 out of 3 
Years Active: 2009-2026
Areas of Expertise:
Title: The Innovative Journey of Inventor Alex Eberlin
Introduction: Alex Eberlin, a prominent inventor based in Cambridge, GB, has made notable contributions to the field of pharmaceuticals, holding a remarkable portfolio of 17 patents. His inventive spirit and dedication to advancing medical science have placed him at the forefront of innovation, particularly in the development of cocrystals that have significant therapeutic potential.
Latest Patents: Eberlin's latest patents showcase his innovative work with cannabidiolic acid and olaparib. His patent on "Cannabidiolic acid cocrystals" presents compositions that include various cocrystals with L-phenylalanine, vanillin, betaine, ethyl maltol, and proline. These compositions, particularly when formulated as pharmaceutical compositions with a suitable carrier, have implications for treating a range of diseases and disorders. Additionally, his invention of "Olaparib hydroxybenzoic acid cocrystals" details new cocrystal formations that are crucial for targeting diseases through poly (ADP-ribose) polymerase (PARP) inhibition. These advancements open doors for innovative treatment methods in modern medicine.
Career Highlights: Throughout his career, Alex Eberlin has brought his inventive genius to various companies, notably Intercept Pharmaceuticals, Inc. and Radius Pharmaceuticals, Inc. His work within these organizations has significantly contributed to pharmaceutical research and development, leading to advancements in therapeutic applications that benefit patients worldwide.
Collaborations: Collaboration has been a key element in Eberlin's success. He has worked alongside talented professionals such as André Steiner and Heidi Waenerlund Poulsen, capitalizing on their expertise to push the boundaries of pharmaceutical innovations and develop groundbreaking solutions.
Conclusion: Alex Eberlin's inventive work has undoubtedly advanced the field of pharmaceuticals, particularly through his development of significant cocrystals. With a total of 17 patents to his name and his ongoing collaborations, Eberlin continues to inspire the next generation of innovators striving to improve healthcare and treatment options. His contributions are a testament to the power of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile